These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8329832)

  • 1. Temporal and individual variations in the dose of glucocorticoid used for the treatment of salt-losing congenital virilizing adrenal hyperplasia due to 21-hydroxylase deficiency.
    Sandrini R; Jospe N; Migeon CJ
    Acta Paediatr Suppl; 1993 Mar; 388():56-60; discussion 61. PubMed ID: 8329832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM; Simm D; Beier C; Dörr HG
    Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment and disease effects on short-term growth and adult height in children and adolescents with 21-hydroxylase deficiency.
    Hauffa BP; Winter A; Stolecke H
    Klin Padiatr; 1997; 209(2):71-7. PubMed ID: 9113619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable efficacy of glucocorticoids in congenital adrenal hyperplasia.
    Hansen JW; Loriaux DL
    Pediatrics; 1976 Jun; 57(6):942-7. PubMed ID: 934750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition by glucocorticoid treatment in salt wasting 21-hydroxylase deficiency: in early infancy and (pre)puberty.
    Stikkelbroeck NM; Van't Hof-Grootenboer BA; Hermus AR; Otten BJ; Van't Hof MA
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3525-30. PubMed ID: 12915631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital adrenal hyperplasia--pharmacologic interventions from the prenatal phase to adulthood.
    Claahsen-van der Grinten HL; Stikkelbroeck NM; Otten BJ; Hermus AR
    Pharmacol Ther; 2011 Oct; 132(1):1-14. PubMed ID: 21635919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Final height in 69 patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
    David M; Sempé M; Blanc M; Nicolino M; Forest MG; Morel Y
    Arch Pediatr; 1994 Apr; 1(4):363-7. PubMed ID: 7842090
    [No Abstract]   [Full Text] [Related]  

  • 8. [11beta-hydroxylase deficiency: improvement of final height with growth hormone and gonadotropin-releasing hormone analog].
    Orío Hernández M; Yebra Yebra J; Bezanilla López C; Gracia Bouthelier R
    An Pediatr (Barc); 2007 Aug; 67(2):153-6. PubMed ID: 17692261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth and skeletal maturation in congenital adrenal hyperplasia. Review of 20 cases.
    Bailey CC; Komrower GM
    Arch Dis Child; 1974 Jan; 49(1):4-7. PubMed ID: 4361889
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucocorticoid treatment of girls with congenital adrenal hyperplasia: effects on height, sexual maturation, and fertility.
    Klingensmith GJ; Garcia SC; Jones HW; Migeon CJ; Blizzard RM
    J Pediatr; 1977 Jun; 90(6):996-1004. PubMed ID: 870661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of prednisolone versus hydrocortisone acetate for treatment of patients with the classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
    Leite FM; Longui CA; Kochi C; Faria CD; Borghi M; Calliari LE; Monte O
    Arq Bras Endocrinol Metabol; 2008 Feb; 52(1):101-8. PubMed ID: 18345402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salt wasting in simple virilizing congenital adrenal hyperplasia.
    Frisch H; Battelino T; Schober E; Baumgartner-Parzer S; Nowotny P; Vierhapper H
    J Pediatr Endocrinol Metab; 2001; 14(9):1649-55. PubMed ID: 11795656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
    Bonfig W; Schwarz HP
    Horm Res Paediatr; 2011; 75(4):264-8. PubMed ID: 21196707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term steroid therapy in patients with adrenogenital syndrome.
    Riddick DH; Hammond CB
    Obstet Gynecol; 1975 Jan; 45(1):15-20. PubMed ID: 163015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Patterns of growth in congenital adrenal hyperplasia. Correlation between glucocorticoid therapy and stature].
    Igea JM; Lóridan L; Martul P; Ferrández A; Mayayo E; Rodríguez M; Oyarzábal M; Elcarte R; Luzuriaga C
    An Esp Pediatr; 1988 Oct; 29 Suppl 35():9-12. PubMed ID: 3272842
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of therapy on mature height in congenital adrenal hyperplasia.
    Kirkland RT; Keenan BS; Holcombe JH; Kirkland JL; Clayton GW
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1320-4. PubMed ID: 263352
    [No Abstract]   [Full Text] [Related]  

  • 17. Circadian patterns of plasma cortisol, 17-hydroxyprogesterone, and testosterone in congenital adrenal hyperplasia.
    Frisch H; Parth K; Schober E; Swoboda W
    Arch Dis Child; 1981 Mar; 56(3):208-13. PubMed ID: 7212759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Moreira RP; Jorge AA; Gomes LG; Kaupert LC; Massud Filho J; Mendonca BB; Bachega TA
    Clinics (Sao Paulo); 2011; 66(8):1361-6. PubMed ID: 21915484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult height in women with early-treated congenital adrenal hyperplasia (21-hydroxylase type): relation to body mass index in earlier childhood.
    Yu AC; Grant DB
    Acta Paediatr; 1995 Aug; 84(8):899-903. PubMed ID: 7488814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Puberty and growth development in patients with a 21-hydroxylase defect].
    Börger D; Willig RP
    Monatsschr Kinderheilkd; 1985 Nov; 133(11):828-33. PubMed ID: 2934617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.